Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Inflammatory Bowel Disease Relief market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Inflammatory Bowel Disease Reliefmarket, defines the market attractiveness level of Inflammatory Bowel Disease Relief market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Inflammatory Bowel Disease Relief industry, describes the types of Inflammatory Bowel Disease Relief market, the applications of major players and the market size, and deeply analyzes the current situation of the global Inflammatory Bowel Disease Relief market and the development prospects and opportunities of Inflammatory Bowel Disease Relief industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Inflammatory Bowel Disease Relief market in Chapter 13.
By Player:
Takeda Pharmaceutical
UCB Inc
Novartis AG
Janssen Biotech
Biogen Inc
Pfizer
Valeant Pharmaceuticals
Allerganplc
AbbVie
Inc(Johnson&Johnson)
By Type:
TNF Inhibitors
Aminosalicylates
Integrin Antagonists
Corticosteroids
Others
By End-User:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Inflammatory Bowel Disease Relief Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Inflammatory Bowel Disease Relief Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Inflammatory Bowel Disease Relief Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Inflammatory Bowel Disease Relief Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Inflammatory Bowel Disease Relief Market Analysis and Outlook to 2022
-
7.1 Global Inflammatory Bowel Disease Relief Consumption (2017-2022)
-
7.2 United States Inflammatory Bowel Disease Relief Consumption (2017-2022)
-
7.3 Europe Inflammatory Bowel Disease Relief Consumption (2017-2022)
-
7.4 China Inflammatory Bowel Disease Relief Consumption (2017-2022)
-
7.5 Japan Inflammatory Bowel Disease Relief Consumption (2017-2022)
-
7.6 India Inflammatory Bowel Disease Relief Consumption (2017-2022)
-
7.7 South Korea Inflammatory Bowel Disease Relief Consumption (2017-2022)
8 Region and Country-wise Inflammatory Bowel Disease Relief Market Analysis and Outlook to 2028
-
8.1 Global Inflammatory Bowel Disease Relief Consumption Forecast (2022-2028)
-
8.2 United States Inflammatory Bowel Disease Relief Consumption Forecast (2022-2028)
-
8.3 Europe Inflammatory Bowel Disease Relief Consumption Forecast (2022-2028)
-
8.4 China Inflammatory Bowel Disease Relief Consumption Forecast (2022-2028)
-
8.5 Japan Inflammatory Bowel Disease Relief Consumption Forecast (2022-2028)
-
8.6 India Inflammatory Bowel Disease Relief Consumption Forecast (2022-2028)
-
8.7 South Korea Inflammatory Bowel Disease Relief Consumption Forecast (2022-2028)
9 Global Inflammatory Bowel Disease Relief Market Outlook by Types and Applications to 2022
-
9.1 Global Inflammatory Bowel Disease Relief Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global TNF Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Aminosalicylates Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Integrin Antagonists Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Corticosteroids Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Inflammatory Bowel Disease Relief Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
10 Global Inflammatory Bowel Disease Relief Market Outlook by Types and Applications to 2028
-
10.1 Global Inflammatory Bowel Disease Relief Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global TNF Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Aminosalicylates Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Integrin Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Inflammatory Bowel Disease Relief Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
11 Global Inflammatory Bowel Disease Relief Import and Export Analysis (Top 5 Countries)
-
11.1 Global Inflammatory Bowel Disease Relief Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Inflammatory Bowel Disease Relief Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Inflammatory Bowel Disease Relief Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Inflammatory Bowel Disease Relief Market Competitive Analysis
-
14.1 Takeda Pharmaceutical
-
14.1.1 Takeda Pharmaceutical Company Details
-
14.1.2 Takeda Pharmaceutical Inflammatory Bowel Disease Relief Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Takeda Pharmaceutical Inflammatory Bowel Disease Relief Product and Service
-
14.2 UCB Inc
-
14.2.1 UCB Inc Company Details
-
14.2.2 UCB Inc Inflammatory Bowel Disease Relief Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 UCB Inc Inflammatory Bowel Disease Relief Product and Service
-
14.3 Novartis AG
-
14.3.1 Novartis AG Company Details
-
14.3.2 Novartis AG Inflammatory Bowel Disease Relief Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis AG Inflammatory Bowel Disease Relief Product and Service
-
14.4 Janssen Biotech
-
14.4.1 Janssen Biotech Company Details
-
14.4.2 Janssen Biotech Inflammatory Bowel Disease Relief Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Janssen Biotech Inflammatory Bowel Disease Relief Product and Service
-
14.5 Biogen Inc
-
14.5.1 Biogen Inc Company Details
-
14.5.2 Biogen Inc Inflammatory Bowel Disease Relief Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Biogen Inc Inflammatory Bowel Disease Relief Product and Service
-
14.6 Pfizer
-
14.6.1 Pfizer Company Details
-
14.6.2 Pfizer Inflammatory Bowel Disease Relief Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Pfizer Inflammatory Bowel Disease Relief Product and Service
-
14.7 Valeant Pharmaceuticals
-
14.7.1 Valeant Pharmaceuticals Company Details
-
14.7.2 Valeant Pharmaceuticals Inflammatory Bowel Disease Relief Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Valeant Pharmaceuticals Inflammatory Bowel Disease Relief Product and Service
-
14.8 Allerganplc
-
14.8.1 Allerganplc Company Details
-
14.8.2 Allerganplc Inflammatory Bowel Disease Relief Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Allerganplc Inflammatory Bowel Disease Relief Product and Service
-
14.9 AbbVie
-
14.9.1 AbbVie Company Details
-
14.9.2 AbbVie Inflammatory Bowel Disease Relief Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 AbbVie Inflammatory Bowel Disease Relief Product and Service
-
14.10 Inc(Johnson&Johnson)
-
14.10.1 Inc(Johnson&Johnson) Company Details
-
14.10.2 Inc(Johnson&Johnson) Inflammatory Bowel Disease Relief Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Inc(Johnson&Johnson) Inflammatory Bowel Disease Relief Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Inflammatory Bowel Disease Relief
-
Figure Inflammatory Bowel Disease Relief Picture
-
Table Global Inflammatory Bowel Disease Relief Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Inflammatory Bowel Disease Relief Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Inflammatory Bowel Disease Relief Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Inflammatory Bowel Disease Relief Consumption by Country (2017-2022)
-
Figure United States Inflammatory Bowel Disease Relief Consumption and Growth Rate (2017-2022)
-
Table Europe Inflammatory Bowel Disease Relief Consumption and Growth Rate (2017-2022)
-
Figure China Inflammatory Bowel Disease Relief Consumption and Growth Rate (2017-2022)
-
Figure Japan Inflammatory Bowel Disease Relief Consumption and Growth Rate (2017-2022)
-
Figure India Inflammatory Bowel Disease Relief Consumption and Growth Rate (2017-2022)
-
Figure South Korea Inflammatory Bowel Disease Relief Consumption and Growth Rate (2017-2022)
-
Figure Global Inflammatory Bowel Disease Relief Consumption Forecast by Country (2022-2028)
-
Figure United States Inflammatory Bowel Disease Relief Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Inflammatory Bowel Disease Relief Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Inflammatory Bowel Disease Relief Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Inflammatory Bowel Disease Relief Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Inflammatory Bowel Disease Relief Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Inflammatory Bowel Disease Relief Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global TNF Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Aminosalicylates Consumption and Growth Rate (2017-2022)
-
Figure Global Integrin Antagonists Consumption and Growth Rate (2017-2022)
-
Figure Global Corticosteroids Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global TNF Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Aminosalicylates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Integrin Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Inflammatory Bowel Disease Relief Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Inflammatory Bowel Disease Relief Export by Region (Top 5 Countries) (2017-2028)
-
Table Takeda Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical Inflammatory Bowel Disease Relief Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Inflammatory Bowel Disease Relief Product and Service
-
Table UCB Inc (Foundation Year, Company Profile and etc.)
-
Table UCB Inc Inflammatory Bowel Disease Relief Sales, Price, Value and Gross Profit (2017-2022)
-
Table UCB Inc Inflammatory Bowel Disease Relief Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Inflammatory Bowel Disease Relief Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Inflammatory Bowel Disease Relief Product and Service
-
Table Janssen Biotech (Foundation Year, Company Profile and etc.)
-
Table Janssen Biotech Inflammatory Bowel Disease Relief Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Biotech Inflammatory Bowel Disease Relief Product and Service
-
Table Biogen Inc (Foundation Year, Company Profile and etc.)
-
Table Biogen Inc Inflammatory Bowel Disease Relief Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Inc Inflammatory Bowel Disease Relief Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inflammatory Bowel Disease Relief Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inflammatory Bowel Disease Relief Product and Service
-
Table Valeant Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Valeant Pharmaceuticals Inflammatory Bowel Disease Relief Sales, Price, Value and Gross Profit (2017-2022)
-
Table Valeant Pharmaceuticals Inflammatory Bowel Disease Relief Product and Service
-
Table Allerganplc (Foundation Year, Company Profile and etc.)
-
Table Allerganplc Inflammatory Bowel Disease Relief Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allerganplc Inflammatory Bowel Disease Relief Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Inflammatory Bowel Disease Relief Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Inflammatory Bowel Disease Relief Product and Service
-
Table Inc(Johnson&Johnson) (Foundation Year, Company Profile and etc.)
-
Table Inc(Johnson&Johnson) Inflammatory Bowel Disease Relief Sales, Price, Value and Gross Profit (2017-2022)
-
Table Inc(Johnson&Johnson) Inflammatory Bowel Disease Relief Product and Service
-
